Saethre-Chotzen syndrome (ACS III)
Introduction
Saethre-Chotzen syndrome (ACS III) is an autosomal dominant craniosynostosis syndrome characterised by craniofacial and limb abnormalities, including variable and asymmetrical craniosynostosis, lid ptosis, small ears with prominent crura, cutaneous syndactyly of the second interdigital space and broad halluces. Additional features including hypertelorism, maxillary hypoplasia and strabismus have been reported. 1 Linkage analyses and fluorescent in situ hybridisation experiments in affected individuals carrying balanced translocations resulted in the mapping of ACS III to chromosome 7p21. [2] [3] [4] [5] [6] Recently, ACS III has been ascribed to mutations in the basic helix-loop-helix (b-HLH) domain of the TWIST gene. 7, 8 This transcription factor plays a key role in regulating mesodermal differentiation and myogenesis in Drosophila. 9, 10 In vertebrates, this factor is apparently involved in negative control of cellular determination and in differentiation of several cell lineages including myogenesis, neurogenesis and osteogenesis. [11] [12] [13] [14] The putative interactions between TWIST and Fibroblast Growth Factor Receptors (FGFRs) via a common signalling pathway are supported by the recent observation that several familial cases of ACS III-like craniosynostosis syndromes and sporadic cases originally diagnosed as ACS III, harboured the recurrent P250R FGFR 3 mutation in the extracellular region of the receptor. [15] [16] [17] [18] Here we report on 16 additional TWIST mutations (including 11 novel mutations) in typical ACS III patients. All these mutations are expected to truncate or disrupt the b-HLH domain of the protein. By contrast, patients harbouring the P250R FGFR 3 mutation had a less severe condition. The absence of TWIST mutations in 40 cases of nonsyndromic coronal craniosynostosis further suggests that TWIST mutations are specific to Saethre-Chotzen syndrome.
Patients and Methods

Patients
A series of 22 patients with syndromic craniosynostosis clinically diagnosed as Saethre-Chotzen syndrome were referred to and treated at Hôpital des Enfants-Malades, Paris. In addition to craniosynostosis manifesting as brachycephaly, plagiocephaly or oxycephaly, at least three of the following criteria were retained for inclusion in the ACS III group: i) lid ptosis ii) abnormal ear with prominent crura iii) cutaneous syndactyly of the second interdigital space iv) broad or duplicated halluces.
Coronal craniosynostosis was unilateral in 8/22 cases (5 rightsided and 3 left-sided plagiocephaly) and bilateral in 9/22 cases (brachycephaly). Five cases had an associated involvement of the sagittal sutures (oxycephaly). The metopic suture was also affected in four patients with either unilateral (2 cases) or bilateral coronal synostosis (2 cases). Additional limb abnormalities included mild 3-5 cutaneous syndactyly (5 cases) and brachydactyly (3 cases). Intrafamilial variability in limb involvement (with or without duplicated big toe) was noted. Other facial abnormalities were also observed, namely lowset frontal hairline (6 cases), epicanthus (6 cases), hypertelorism (5 cases) and strabismus (4 cases). Most patients had an IQ from 90 to 120 and three individuals had an obvious developmental delay (IQ: 50-70) without any evidence of chromosomal rearrangement. No increase in paternal age was found.
A second group of 40 patients with non-syndromic coronal craniosynostosis was investigated for mutations in the TWIST gene.
DNA Analyses
Blood samples were obtained with the written consent of the patients and non-affected relatives. The whole coding sequence of the TWIST gene was amplified in two overlapping fragments of 461 and 371 nt respectively by using two sets of primers -first set: forward primer 5' GCAAGCGCGGCAAGAAGTCT 3'; reverse primer 5' GGGGTGCAGCGGCGCGGTC 3'; second set: forward primer 5' GAGGCGCCCCGCTCTTCTCC 3'; reverse primer 5' CCTCGTAAGACTGCGGACTC 3'. Genomic DNA was PCR amplified using 15 pmoles of each primer, 200µM dNTP, 5% DMSO and 1 U Taq polymerase in a final volume of 50 µl. Amplified fragments were analysed by single strand conformation polymorphism (SSCP) on Hydrolink MDE gels after digestion of the 461 nt fragment by restriction enzyme Rsa I. Amplification products showing abnormal patterns of migration were reamplified and sequenced by using the fluorescent dideoxy terminator method on an automatic sequencer ABI. When insertions or deletions were detected by direct sequencing of PCR products, the mutant and normal alleles were cloned into the vector pCR 3 using the TA cloning kit (In vitrogen); individual clones were randomly sequenced. In order to study the unique intron, the following primers were designed: forward 5' CGGAGCCCCCCACCCCCT 3', reverse 5' CTGTCCATTTTCTCCTTCTCTG 3'. A 609 bp amplimer was generated and submitted to SSCP analysis after restriction digestion, then to direct sequencing. Two other primers (forward 5' GGTTTGGGAGGACGAATTGT 3'; reverse 5' GCTCTTCCTCGCTGTTGCTC 3') were chosen for sequencing of the promoter region. The non-translated exon 2 was amplified using two sets of overlapping primers -first set: forward 5' CCTAAACAATAACCGACTCC 3'; reverse 5' GTTCCTCTGATTGTTACCATT 3'; second set: forward 5' CAAGAGGTCGTGCCAATCAG 3'; reverse 5' CCAAATCTAAGGTTCTCTAAATT 3'.
Resequencing of the TWIST gene revealed discrepancies with respect to the previously reported sequence 19 (accession number X99268). In agreement with Howard et al, 8 the TWIST protein is encoded by 202 aminoacids (instead of 206). Mutations previously reported 7 were renumbered accordingly.
To study the FGFR 3 gene, primers located in introns 6 and 7 were used to amplify a 337 nt fragment 20 which was separated on 4% metaphor gels (FMC) following digestion with Nci I (New England Biolabs). Detection of an additional 151 nt band was followed by sequence analysis of the mutant DNA. Figure 1 ). Nonsense mutations and frameshift deletions/insertion consistently occurred within (7/12) or upstream to the b-HLH domain of the protein in our series (5/12). Missense mutations affected highly conserved residues in the loop (3/4) or helix 2 (1/4). In 6/22 ACS III patients (three familial forms and three sporadic cases), no mutations in exon 1 were found despite SSCP and sequence analyses. Moreover, no base changes were found in the promoter region, in untranslated exon 2 or in the splice junctions of the TWIST gene. However, in two familial cases (2/6), the P250R FGFR 3 mutation was present and segregated with the disease (result not shown).
Results
Mutation Analysis in the TWIST Gene
On the other hand, screening 40 cases of nonsyndromic coronal craniosynostosis failed to detect TWIST mutations.
Genotype-Phenotype Correlations in ACS III Patients
In an attempt to correlate mutant genotypes with clinical phenotypes, ACS III patients harbouring TWIST mutations were re-examined clinically. Both the patients reported by El Ghouzzi et al 7 and those reported in this study were investigated and split into three groups, based on (Table 1) .
It appeared that all affected individuals had ptosis, small round ears and/or crus helicis and 2-3 cutaneous syndactyly regardless of the molecular subtypes and no clinical differences between the three groups were noted. It is worth noting that patients who failed to harbour TWIST or FGFR 3 mutations were clinically indistinguishable from those carrying TWIST mutations, whilst patients carrying the P250R FGFR 3 mutation had a less severe phenotype, including moderate ptosis, normal size ears and mild cutaneous syndactyly 2-3 ( Figure 2 ).
Discussion
Based on the analysis of a series of 22 unrelated Saethre-Chotzen patients, the present study shows that most mutations involved the b-HLH domain of the TWIST gene in ACS III (16/22) . The newly identified TWIST mutations consisted in nonsense, missense mutations and frameshift deletions/insertions in the b-HLH domain. A total of 40 TWIST gene mutations (summarized in Figure 3 ) have been hitherto identified in ACS III 7, 8, 17 (and this study) and some of them proved to be recurrent. In particular, the rate of C-to-G/A transversions at nucleotide 309 looked unexpectedly high (10%). Nonsense mutations (37.5%) and frameshift deletions or insertions (12.5%) were predicted to either truncate or disrupt the b-HLH motif of the protein, whereas missense mutations in the HLH region (25%) and the 7 aminoacids in frame insertions (20%) most likely altered the secondary/tertiary structure of the b-HLH domain thus hampering dimerisation. These features along with the phenotypic expression of M-Twist null heterozygous mutations in mice 7 support the view that haploinsufficiency or loss of function at the TWIST locus are the major mechanisms of ACS III. Along these lines, it is worth remembering that Waardenburg syndrome type II is also caused by loss-of-function mutations of the MITF gene, a transcriptional factor with a b-HLH domain and a leucine zipper activity. 21 Yet the molecular mechanism underlying the disease remains questionable. Since TWIST belongs to the tissue-specific class B b-HLH proteins, one can hypothesise that truncated TWIST proteins either fail to form stable homodimers or heterodimerise with E proteins (the product of E2 genes), a group of widely expressed class A b-HLH proteins which preferentially dimerise with class B b-HLH proteins. 22, 23 Point mutations in the basic region of E47 were shown to prevent DNA binding without altering heterodimer formation. 24 Consequently, the presence of missense mutations at equivalent residues in the DNA-binding domain of TWIST (in 2/40 patients) suggests a dominant negative effect in these two cases. 25 However, the recent On the other hand, it is worth noting that 4/22 ACS III patients failed to harbour TWIST mutations in our series. One can speculate that these patients carry short scale deletions flanking the TWIST gene and downregulating its expression via a positional effect, especially as a translocation deletion located 5 kb downstream from the TWIST gene has been recently described in association with mild ACS III. 26 Interestingly, such a positional effect has been previously reported for PAX 6 in aniridia, 27 GLI 3 for Greig syndrome 28 and SOX 9 for campomelic dysplasia. 29 Re-examination of clinical symptoms in our ACS III patients carrying TWIST mutations revealed that they consistently presented a ptosis with 2-3 syndactyly of the hands and abnormal ears (round and small with TWIST gene mutations in Saethre-Chotzen syndrome V El Ghouzzi et al t frequent crus helicis) regardless of the molecular subtype. Broad or duplicated halluces were otherwise frequent, while hypertelorism, epicanthus, lowset frontal hairline and brachydactyly were inconstant. Interestingly, no correlation between clinical phenotypes and mutant genotypes at the TWIST locus could be found in our series suggesting that most mutations result in non-functional proteins.
Two patients originally diagnosed as Saethre-Chotzen syndrome harboured the recurrent P250R mutation in FGFR 3 as previously reported. 16, 17 On clinical re-examination, both patients appeared to have a milder phenotype than typical ACS III individuals. Yet the phenotypical overlap of patients with TWIST and P250R FGFR 3 mutations further supports the view that the two factors are involved in a common signalling pathway during craniofacial and limb development, 7, 8 especially as a drosophila homolog of FGFRs (DFR-1/heartless) acts as a target for the TWIST protein during Drosophila mesodermal differentiation. 30 Finally, since no TWIST mutations were found in a large series of 40 non-syndromic coronal craniosynostoses, it appears that TWIST mutations are specific to Saethre-Chotzen syndrome. Considering that diagnosing ACS III is frequently difficult, owing to clinical variability and phenotypic overlap with coronal craniosynostoses, the present study suggests that screening for both TWIST and the P250R FGFR 3 mutation is required for accurately diagnosing this condition. Rose et al. 17 Numbers in parentheses correspond to recurrent mutations.
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